SIDP EFISG Martin Hoenigl🇺🇦🇦🇹 Some good examples from the literature of combination AF the therapy in cryptococcal
Meningitis, candidemia, and aspergillosis #antifungal #ECCMID2024 #ESCMIDGlobal2024

Our article in Lancet Infectious Diseases about Yellow Fever, cited today in this conference at ESCMID Global 2024.
Andrés Henao, MD, FIDSA Daniel Chastain
thelancet.com/journals/lanin…

Epidemiological trends and clinical outcomes of cryptococcosis in a medically insured population in the United States... Daniel B. Chastain, et al. Therapeutic Advances in Infectious Disease. 2024, 11: 1-16. doi.org/10.1177/204993… hdl.handle.net/10045/142343 Jose Tuells

Investigating cryptococcosis trends & outcomes in 3 patient groups: HIV,SOT & non HIV/transplant (NHNT). 📈 Increasing incidence and higher mortality observed in NHNT cohort #Cryptococcosis Daniel Chastain Andrés Henao, MD, FIDSA George Thompson journals.sagepub.com/doi/full/10.11…

Fantastic overview of ART in the ICU cc Shantegravir

Clinical Infectious Diseases Daniel Chastain, I just used this the other day! #IDTwitter

Executive Summary: State-of-the-Art Review: Unintended Consequences: Risk of Opportunistic Infections Associated with Long-term Glucocorticoid Therapies in Adults

🆓 Freely Available
bit.ly/3Q1Npfs

Melat Endashaw from Tucker, GA will be heading to Emory University Hospital Midtown in Atlanta, GA! Mentored by Daniel Chastain Daniel Chastain and Jordan Khail. Way to go Melat! #UGAMatch2024

Daniel Rogers will be completing PGY-2 training in Infectious Diseases at Emory University Hospital Midtown in Atlanta, GA. Mentored by Dr. Kristen Paciullo and Dr. Daniel Chastain Daniel Chastain. Way to go Daniel! #UGAMatch2024

Risk of Invasive Fungal Infections in Patients with Chronic Lymphocytic Leukemia treated with Bruton Tyrosine Kinase Inhibitors – A Case-Control Propensity Score Matched Analysis

✅ Just Accepted
🔓 Open Access
🔗 bit.ly/3UYbcAr

Huge thanks to Andrés Henao, MD, FIDSA Jose Andres Henao Cordero MD Jose Tuells for the fantastic opportunity to collaborate on our research investigating the risk of invasive fungal infections in patients w/ CLL treated w/ a BTKi
Check out our findings here: academic.oup.com/ofid/advance-a…

🆕️⚡️⚡️Case-Control Propensity Score Matched Analysis Open Forum Infectious Diseases
Risk of Invasive Fungal Infections in Patients with Chronic Lymphocytic Leukemia treated with Bruton Tyrosine Kinase Inhibitors (BTKi) #IDXposts academic.oup.com/ofid/article/d…

When #local is #GlobalHealth

Positive #Toxoplasma IgG Serology Is Associated with Increased Overall Mortality – A PSM Analysis

Multifactorial, perhaps mediated by SDH, Tx availability and schizophrenia risk

CU Department of Medicine CU Infectious Diseases Am J Trop Med Hyg

doi.org/10.4269/ajtmh.…

Huge thanks to Alice Han for sharing our article on the risks of OIs in patients on glucocorticoid therapy. Check out the great thread below and explore our review (doi.org/10.1093/cid/ci…). Net immunosuppression calculator would be great!
Andrés Henao, MD, FIDSA

Do you have plans tomorrow afternoon from 3:45-4:45 at #ASHP23 ? Come listen to a talk on bacteremia treatment duration by me and Daniel Chastain. OU College of Pharmacy Residency Program UGA College of Pharmacy UMMC Pharmacy

Is #DM2 a risk factor for #Cryptococcosis ?

Although, #Cryptococcosis has been described in otherwise immunocompetent patients, the role of #DM2 as a RF remains unclear.

A small🧵

CU Infectious Diseases RUA Springer Nature

pubmed.ncbi.nlm.nih.gov/37907808/